Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and …
Objective: To compare the efficacy and tolerability of tricyclic antidepressants with selective
serotonin reuptake inhibitors in depression in primary care. Design: Systematic review and …
serotonin reuptake inhibitors in depression in primary care. Design: Systematic review and …
Dual monoamine modulation for improved treatment of major depressive disorder
PV Tran, FP Bymaster, RK McNamara… - Journal of clinical …, 2003 - journals.lww.com
The worldwide scope of depressive illness and lack of fully effective pharmacotherapy
mandates significant improvements in treatment paradigms. Current antidepressant …
mandates significant improvements in treatment paradigms. Current antidepressant …
The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome
F Creed, L Fernandes, E Guthrie, S Palmer, J Ratcliffe… - Gastroenterology, 2003 - Elsevier
Background & Aims: Psychotherapy and antidepressants are effective in patients with
severe irritable bowel syndrome (IBS), but the cost-effectiveness of either treatment in …
severe irritable bowel syndrome (IBS), but the cost-effectiveness of either treatment in …
Evaluation of the adequacy of outpatient antidepressant treatment
JB Weilburg, KM O'Leary, JB Meigs… - Psychiatric …, 2003 - Am Psychiatric Assoc
OBJECTIVE: Most studies evaluating the adequacy of antidepressant treatment have
focused on the relatively small segment of the medicated population with a diagnosis of …
focused on the relatively small segment of the medicated population with a diagnosis of …
Nortriptyline for treatment-resistant depression
AA Nierenberg, GI Papakostas, T Petersen… - Journal of Clinical …, 2003 - psychiatrist.com
Background: Up to 30% of patients with major depression fail to respond to an
antidepressant trial, with most taking a selective serotonin reuptake inhibitor (SSRI) as initial …
antidepressant trial, with most taking a selective serotonin reuptake inhibitor (SSRI) as initial …
Escitalopram: a pharmacoeconomic review of its use in depression
KF Croom, GL Plosker - Pharmacoeconomics, 2003 - Springer
Escitalopram (Cipralex®), a new highly selective serotonin reuptake inhibitor (SSRI), is the
active S-enantiomer of RS-citalopram. It is effective in the treatment of patients with major …
active S-enantiomer of RS-citalopram. It is effective in the treatment of patients with major …
A self-controlled, naturalistic study of selective serotonin reuptake inhibitors versus tricyclic antidepressants
C Faravelli, F Cosci, M Ciampelli… - Psychotherapy and …, 2003 - karger.com
Objective: To compare the effectiveness of serotonin reuptake inhibitors (SSRIs) and tricyclic
antidepressants (TCAs) for anxiety and mood disorders in a naturalistic setting. Methods …
antidepressants (TCAs) for anxiety and mood disorders in a naturalistic setting. Methods …
Antidepressants: psychiatrists' opinions and clinical practice
F Depont, S Rambelomanana, S Le Puil… - Acta Psychiatrica …, 2003 - Wiley Online Library
Objective: To describe and compare psychiatrists' opinion on antidepressant drugs and their
prescriptions to depressed patients. Method: Between January and September 1999 a …
prescriptions to depressed patients. Method: Between January and September 1999 a …
Clinical trial response and dropout rates with olanzapine versus risperidone
B Santarlasci, A Messori - Annals of Pharmacotherapy, 2003 - journals.sagepub.com
BACKGROUND: In schizophrenia, comparing treatment dropouts between olanzapine and
risperidone can be useful to better understand their relative effectiveness. OBJECTIVE: To …
risperidone can be useful to better understand their relative effectiveness. OBJECTIVE: To …
[图书][B] Subtle psychological side effects: documentation, description, and treatment implications of subjective experiences of selective serotonin reuptake inhibitors …
MY Bolling - 2003 - search.proquest.com
Psychological side effects may affect patients' willingness to continue or return to SSRI
treatment, and may be one reason for client dissatisfaction with medication. The goal of this …
treatment, and may be one reason for client dissatisfaction with medication. The goal of this …